0001685428-20-000006.txt : 20201215 0001685428-20-000006.hdr.sgml : 20201215 20201215162623 ACCESSION NUMBER: 0001685428-20-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 EFFECTIVENESS DATE: 20201215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LumiraDx Ltd CENTRAL INDEX KEY: 0001685428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383288 FILM NUMBER: 201389875 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ BUSINESS PHONE: 011 44 1786 430411 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ D 1 primary_doc.xml X0708 D LIVE 0001685428 LumiraDx Ltd 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2AQ 011 44 1786 430411 CAYMAN ISLANDS None None Other Exempted company limited by shares true 2016 Ron Zwanziger c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Scott c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director Jerry McAleer c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Walton c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Nigel Lindner c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Veronique Ameye c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Tom Quinlan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Peter Scheu c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Dorian LeBlanc c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Donald Berwick c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Bruce Keogh c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lurene Joseph c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lu Huang c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Troyen Brennan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Amit Thakker c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director George Neble c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Gerald Chan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Other Health Care Decline to Disclose 06b false 2020-11-30 false true false 0 U.S. Boston Capital Corporation 5251 None None 55 Old Bedford Road Lincoln MA MASSACHUSETTS 01773 All States false 164000000 164000000 0 Amount sold shown in item 13 and number of investors in item 14 includes $105,500,000 from three non-US investors. false 31 1230000 true 0 US Boston Capital Corp. receives an administrative fee and a placement fee based on amount sold. A portion of the fee was paid in preferred shares. 0 false LumiraDx Ltd /s/ Veronique Ameye Veronique Ameye Executive Vice President & General Counsel 2020-12-15